In this update, I'll focus on Organon's Q3 2024 results, earnings adjustments and segment performance, as well as the ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

Organon is paying $175 million upfront to buy Roivant's dermatology unit Dermavant and its topical psoriasis therapy Vtama, which is also under review by the FDA for atopic dermatitis. The AI ...

Organon is paying $175 million upfront to buy Roivant's dermatology unit Dermavant and its topical psoriasis therapy Vtama, which is also under review by the FDA for atopic dermatitis. The AI ...

Leerink Partners analyst David Risinger has reiterated their bullish stance on ROIV stock, giving a Buy rating yesterday. David Risinger has ...

Organon Philippines, a women’s health company, recently unveiled its Her Health Finder, an online tool that aims to empower women to take control of their health by providing quick, easy access ...

JERSEY CITY, N.J. (AP) — JERSEY CITY, N.J. (AP) — Organon & Co. (OGN) on Thursday reported third-quarter profit of $359 million. On a per-share basis, the Jersey City, New Jersey-based company ...

TD Cowen analyst Yaron Werber maintained a Buy rating on Roivant Sciences (ROIV – Research Report) yesterday. The company’s shares closed yesterday at $11.64. According to TipRanks, Werber is a 5-star ...

Van ECK Associates Corp boosted its position in Organon & Co. (NYSE:OGN – Free Report) by 32.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Trump Taps Matt Gaetz for Attorney General, a Provocative Move President-elect Trump plans to nominate the Florida congressman, among a flurry of personnel announcements as Republicans neared ...